Inventor · disambiguated record
Marc I. Damelin
Also filed as: DAMELIN MARC · DAMELIN MARC I · DAMELIN MARC ISAAC
8 granted patents·9 pending applications·19 citations·filing 2002–2025
80Inventor score
Top patents by PatentIndex Score
17 records- 0192US12156870B2Antibody drug conjugates comprising sting agonistsMERSANA THERAPEUTICS INC·Filed 2022·Granted Dec 3, 2024·1 cites·30 claims
- 0290US9777070B2Anti-PTK7 antibody-drug conjugatesPFIZER·Filed 2015·Granted Oct 3, 2017·14 cites·60 claims
- 0380US12440576B2Antibody drug conjugates comprising sting agonistsMERSANA THERAPEUTICS INC·Filed 2022·Granted Oct 14, 2025·0 cites·20 claims
- 0480US2025352662A1Antibody drug conjugates comprising sting agonistsMERSANA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0573US9340774B2Tumor-initiating cells and methods for using sameDAMELIN MARC ISAAC·Filed 2010·Granted May 17, 2016·4 cites·11 claims
- 0672US2024148887A1Site specific antibody-drug conjugates with peptide-containing linkersMERSANA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0771US2024269306A1B7h4-targeted antibody-drug conjugates and methods of use thereofMERSANA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0870US9381205B2Anti-EFNA4 antibody-drug conjugatesPFIZER·Filed 2014·Granted Jul 5, 2016·0 cites·27 claims
- 0969US2022378749A1Antibody drug conjugates comprising sting agonistsMERSANA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1067US11964024B2B7H4-targeted antibody-drug conjugates and methods of use thereofMERSANA THERAPEUTICS INC·Filed 2022·Granted Apr 23, 2024·0 cites·30 claims
- 1167US11786605B2Site specific antibody-drug conjugates with peptide-containing linkersMERSANA THERAPEUTICS INC·Filed 2021·Granted Oct 17, 2023·0 cites·8 claims
- 1262US9872922B2Anti-EFNA4 antibody-drug conjugatesPFIZER·Filed 2016·Granted Jan 23, 2018·0 cites·25 claims
- 1360US2023398229A1Antibody drug conjugates comprising sting agonists, combinations and methods of useMERSANA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1457US2018296691A1Anti-efna4 antibody-drug conjugatesPFIZER·Filed 2018·Application pending·0 cites
- 1550US2016326496A1Tumor-initiating cells and methods for using sameWYETH LLC·Filed 2016·Application pending·0 cites
- 1646US2018094075A1Anti-ptk7 antibody-drug conjugatesPFIZER·Filed 2017·Application pending·0 cites
- 1740US2003013142A1In vivo protein-protein interaction mappingDANA FARBER CANCER INST INC·Filed 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Marc I. Damelin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →